» Articles » PMID: 12181572

Transcriptional Co-activator PGC-1 Alpha Drives the Formation of Slow-twitch Muscle Fibres

Overview
Journal Nature
Specialty Science
Date 2002 Aug 16
PMID 12181572
Citations 1131
Authors
Affiliations
Soon will be listed here.
Abstract

The biochemical basis for the regulation of fibre-type determination in skeletal muscle is not well understood. In addition to the expression of particular myofibrillar proteins, type I (slow-twitch) fibres are much higher in mitochondrial content and are more dependent on oxidative metabolism than type II (fast-twitch) fibres. We have previously identified a transcriptional co-activator, peroxisome-proliferator-activated receptor-gamma co-activator-1 (PGC-1 alpha), which is expressed in several tissues including brown fat and skeletal muscle, and that activates mitochondrial biogenesis and oxidative metabolism. We show here that PGC-1 alpha is expressed preferentially in muscle enriched in type I fibres. When PGC-1 alpha is expressed at physiological levels in transgenic mice driven by a muscle creatine kinase (MCK) promoter, a fibre type conversion is observed: muscles normally rich in type II fibres are redder and activate genes of mitochondrial oxidative metabolism. Notably, putative type II muscles from PGC-1 alpha transgenic mice also express proteins characteristic of type I fibres, such as troponin I (slow) and myoglobin, and show a much greater resistance to electrically stimulated fatigue. Using fibre-type-specific promoters, we show in cultured muscle cells that PGC-1 alpha activates transcription in cooperation with Mef2 proteins and serves as a target for calcineurin signalling, which has been implicated in slow fibre gene expression. These data indicate that PGC-1 alpha is a principal factor regulating muscle fibre type determination.

Citing Articles

Molecular breeding of pigs in the genome editing era.

Chen J, Wang J, Zhao H, Tan X, Yan S, Zhang H Genet Sel Evol. 2025; 57(1):12.

PMID: 40065264 PMC: 11892312. DOI: 10.1186/s12711-025-00961-7.


Skeletal muscle atrophy and dysfunction in obesity and type-2 diabetes mellitus: Myocellular mechanisms involved.

Castillo I, Argiles J, Rueda R, Ramirez M, Pedrosa J Rev Endocr Metab Disord. 2025; .

PMID: 40064750 DOI: 10.1007/s11154-025-09954-9.


Metabolic dysregulation contributes to the development of dysferlinopathy.

Furrer R, Dilbaz S, Steurer S, Santos G, Karrer-Cardel B, Ritz D Life Sci Alliance. 2025; 8(5).

PMID: 40021220 PMC: 11871293. DOI: 10.26508/lsa.202402991.


Microgravity Accelerates Skeletal Muscle Degeneration: Functional and Transcriptomic Insights from a Muscle Lab-on-Chip Model Onboard the ISS.

Parafati M, Thwin Z, Malany L, Coen P, Malany S bioRxiv. 2025; .

PMID: 39974935 PMC: 11838239. DOI: 10.1101/2025.01.26.634580.


A 6-Minute Limb Function Assessment for Therapeutic Testing in Experimental Peripheral Artery Disease Models.

Palzkill V, Tan J, Moparthy D, Tice A, Ferreira L, Ryan T JACC Basic Transl Sci. 2025; 10(1):88-103.

PMID: 39906594 PMC: 11788496. DOI: 10.1016/j.jacbts.2024.08.011.